4-146803559-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_031956.4(TTC29):c.1228C>A(p.Leu410Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000106 in 1,605,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_031956.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC29 | NM_031956.4 | c.1228C>A | p.Leu410Ile | missense_variant | 11/13 | ENST00000325106.9 | NP_114162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC29 | ENST00000325106.9 | c.1228C>A | p.Leu410Ile | missense_variant | 11/13 | 1 | NM_031956.4 | ENSP00000316740.4 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000424 AC: 1AN: 235914Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 127492
GnomAD4 exome AF: 0.00000275 AC: 4AN: 1453622Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 722152
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.1228C>A (p.L410I) alteration is located in exon 11 (coding exon 9) of the TTC29 gene. This alteration results from a C to A substitution at nucleotide position 1228, causing the leucine (L) at amino acid position 410 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at